Professor Wong, Ian Chi Kei 黃志基
Professor Wong is Co-Director of the Centre for Safe Medication Practice and Research, Department of Pharmacology & Pharmacy, and holder of the Lo Shiu Kwan Kan Po Ling Professorship in Pharmacy at HKU. He is Co-Director of the Centre for Medication Optimisation Research and Education (CMORE) at University College London Hospital and UCL School of Pharmacy.
His expertise is using big data research to investigate safety and optimum use of medications for treatment of various conditions specifically cardiovascular, neurological and psychological conditions. As part of this work, he conducts research at Queen Mary Hospital, Hong Kong to evaluate the safety and effectiveness of medication in patients with these and other illnesses
Professor Wong qualified as a pharmacist in 1992 and received his PhD from The University of Manchester in 1998 for his work at the David Lewis Centre for Epilepsy. In 2002, he was appointed as the Founding Director of the Centre for Paediatric Pharmacy Research at the School of Pharmacy, University of London, and the UCL Institute of Child Health and Great Ormond Street Hospital, which is recognised as a leading research centre in medicines for children.
After joining HKU in 2011 as Head of the Department of Pharmacology & Pharmacy, Professor Wong led the accreditation of the BPharm programme by the Pharmacy and Poisons Board of Hong Kong. He was also responsible for setting up the new Master of Clinical Pharmacy programme and the Centre for Safe Medication Practice and Research. The Centre for Safe Medication Practice and Research has focused on the methodological development and application of health big data research in Hong Kong. In 2015, in addition to his work at HKU, Professor Wong took up his dual role at UCL to develop a joint research programme in pharmacoepidemiology and medication safety.
Professor Wong has also advised the Departments of Health in England and Hong Kong, the World Health Organization, the European Medicines Agency, and the pharmaceutical industry. He has over 400 peer-reviewed papers published in prominent journals and is an Executive Editor of British Journal of Clinical Pharmacology. Professor Wong was cited among the top 1% of scholars in the Clarivate Analytics' Essential Science Indicators in seven consecutive years between 2015 and 2021.
In recognition of his research, Professor Wong has received various awards and fellowships for his work as an academic pharmacist. He was awarded the Chemist and Druggist Pharmacy Practice Research Conference Medal from the Royal Pharmaceutical Society of Great Britain in 2004. He is the only pharmacist to date to have received a UK Department of Health Public Health Career Scientist Award in 2002. He was awarded an Honorary Fellowship from the Royal College of Paediatrics and Child Health in the UK in 2011, an Honorary Fellowship from the College of Pharmacy Practice in Hong Kong in 2013, and a Fellowship from the Royal Pharmaceutical Society of Great Britain in 2013, British Pharmacological Society 2019 and International Society of Pharmacovigilance in 2019.
Professor Wong was Vice-President of the International Society of Pharmacovigilance between 2016 and 2019. He has also been an expert witness for many legal cases in the UK and Hong Kong regarding medication safety on behalf of victims of medication errors and adverse drug reactions, and for pharmaceutical companies.
|Awardees||Award Date||Honours / Awards / Prizes||Category|
|2019-05-01||Faculty Outstanding Research Output Award 2021: Faculty of Medicine||Research Achievement|
|2019-02-01||Faculty Outstanding Research Output Award 2020: Faculty of Medicine||Research Achievement|
|2019-05-01||Faculty Outstanding Research Output Award 2020: Faculty of Medicine||Research Achievement|
|2021-11-01||2021 Healthy Longevity Catalyst Awards (Hong Kong): U.S. National Academy of Medicine (NAM)||Research Achievement|
|2020-02-01||Faculty Outstanding Research Output Award,: The University of Hong Kong||Research Achievement|
|2021-01-01||Best Abstract Award in Clinical Medicine in 26th Medical Research Conference (ePoster oral presentation): The University of Hong Kong||Research Achievement|
|2020-06-01||HKCFP Best Research Award 2019 for the paper " Relative importance, healthy life-year lost and population attributable risk of modifiable risk factors on cardiovascular disease in a 10-year Diabetes Cohort.: Hong Kong College of Family Physicians (HKCFP)||Research Achievement|
|2020-09-01||Best Research Paper Award for "Is chronic kidney disease equally important as cardiovascular disease in 3 million adults? A 10-year retrospective cohort study.": Hong Kong Primary Care Conference 2020||Research Achievement|
|2018-10-01||Faculty Outstanding Research Output Award 2019: Faculty of Medicine, The University of Hong Kong||Research Achievement|
|2019-08-01||Faculty Outstanding Research Output Award: Faculty of Medicine, The University of Hong Kong||Research Achievement|
|2018-01-01||Best Abstract Award in Clinical Medicine, 23rd Medical Research Conference (oral presentation), Hong Kong: The University of Hong Kong||Research Achievement|
|2018-01-01||Faculty Outstanding Research Output Award: Faculty of Medicine, The University of Hong Kong||Research Achievement|
|2012-11-02||Interprofessional online learning for dementia (IPOLD): Teaching Development Grants (TDG) awards||Teaching Accomplishment|
|2002-09-01||National Public Health Career Scientist Award: Department of Health in England||Research Achievement|
|1999-09-01||John M Harrison Award (Travel): College of Pharmacy Practice in England||Research Achievement|
|2004-09-01||Chemist and Druggist Pharmacy Practice Research Conference Medal 2004: Royal Pharmaceutical Society of Great Britain||Research Achievement|
|2014-05-01||Teaching Development Grants (TDG) Award: The University of Hong Kong||Teaching Accomplishment|
|2016-08-01||Faculty Outstanding Research Output Award: Faculty of Medicine, The University of Hong Kong||Research Achievement|
|2017-09-01||Faculty Outstanding Research Output Award: Faculty of Medicine, The University of Hong Kong||Research Achievement|
|Term Period||Position||Professional Societies|
|09/2018-08/2020||Visiting Professor||Taylor's University|
|06/2013 to 05/2016||Chair||Examination Committee Pharmacy and Poisons Board|
|05/2011||External Assessor for promotion||University of Malaya|
|10/2012-09/2015||Member of General Committee||International Society of Pharmacovigilance|
|10/2015-11/2019||Vice-President||International Society of Pharmacovigilance|
|01/2012-12/2012||Member of Executive Committee||Hong Kong Pharmaceutical Society|
|09/2012-09/2014||Member||Pharmacy and Poisons Board|
|09/2019-08/2021||Member||Pharmacy and Poisons Board|
|11/2010-02/2012)||Member of Epilepsy Guideline Group||National Institute for Health and Clinical Excellence (NICE)|
|11/2011||External Examiner||Universiti Sains Malaysia|
|04/2016-03/2018||Member of NICE Guideline Development Group||National Institute for Health and Care Excellence|
|01/2013 to 06/2013||Grant reviewer of Medical and Health Research Fund||Food and Health Bureau, HKSAR|
|05/2012-upon the completion of the strategic review||Member of the Pharmacists Sub-group of the Steering Committee on Strategic Review on Healthcare Manpower Planning and Professional Development||Food and Health Bureau, HKSAR|
|06/2013 to 05/2016||Chair||Internship Training Committee Pharmacy and Poisons Board|
|01/2016-03/2021||Member of Independent Scientific Committee of CPRD||Medicines and Healthcare Products Regulatory Agency (UK)|
|11/2012 to 11/2017||Member of Assessment Panel for Health and Medical Research Fund Commissioned Programme on Phase 1 Clinical trials||Food and Health Bureau, HKSAR|
Are You Missing Publications, Invited Lectures? Click Me.